Pharmacopeia
(Nasdaq: PCOP), an innovator in the discovery and development of novel
small molecule therapeutics, announced that results from the
company’s Phase 2a clinical trial evaluating PS433540, its first-in-class
Dual Acting Receptor Antagonist (DARA), will be presented as a
late-breaking clinical trial at the American Society of Hypertension (ASH)
Twenty-Third Annual Scientific Meeting and Exposition Read more…
Morria Biopharmaceuticals Plc, a
biopharmaceutical company focused on the development of novel
anti-inflammatory drugs, announced that it has obtained regulatory
approval from the South African Medicines Control Council (MCC) to initiate
a Phase II study of MRX-4 in 105 patients suffering from allergic rhinitis
(AR). The two-arm, randomized, multi-dose, double-blind, placebo-controlled
study includes a steroid comparator arm.
The Read more…
The results of new research on blood pressure
announced today reveal that despite Irish people getting their blood
pressure checked, the majority of them do not know what their reading is
(1). The research was commissioned by Boehringer Ingelheim in advance of
World Hypertension Day 2008 this Saturday, 17th May. High Read more…
Men’s Health News
Less educated, older men are more likely to view depression negatively, while almost one in five Australians say they wouldn’t work with someone suffering depression, according to researchers from The Australian National University.
The research, published today by online open access journal BioMed Central, highlights the need for targeted programs to reduce levels of stigma attached to depression. The work was conducted Read more…
The blood circulates through the body in an intricate process that researchers are only beginning to understand. Now, University of Missouri researcher Steven Segal has received the National Heart, Lung and Blood Institute’s prestigious Method to Extend Research in Time (MERIT) Award for his work in defining the signaling processes that control blood flow in the Read more…
The children of parents who die suddenly - whether by suicide, accident or natural causes - are three times more likely to develop depression and are at higher risk for post-traumatic stress disorder (PTSD) than children who don’t face such a difficult life event, according to a University of Pittsburgh School of Medicine study published in the Read more…
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the initiation of
ATHENA-1, a Phase IV, randomized, double-blind, placebo-controlled study evaluating Letairis®
(ambrisentan 5 mg and 10 mg tablets) in patients with pulmonary arterial hypertension (PAH)
demonstrating a sub-optimal response to sildenafil monotherapy. ATHENA-1 is the first of several
Phase IV Letairis studies Gilead plans to initiate in 2008 and 2009. Read more…
Boehringer Ingelheim GmbH announced an agreement to acquire Actimis Pharmaceuticals, Inc., a privately owned biotech company based in San Diego. The acquisition will occur through a structured buyout in which Boehringer Ingelheim will acquire shares of Actimis depending on the achievement of several successive milestones with Actimis’ leading asthma compound AP768. If AP768, currently in phase I clinical development, is successfully advanced into a phase III, Boehringer Ingelheim Read more…
Moving house or the separation of parents can significantly increase the risk of children developing allergies later on. These are the results from a long-term study correlating life-style, immune system development and allergies, led by the Helmholtz Center for Environmental Research in Leipzig (UFZ), the Helmholtz Zentrum Munchen and the "Institut f??r Umweltmedizinische Forschung" (IUF) in Duesseldorf. The researchers Read more…
This study investigates the relationship between personality constructs and different anxiety types among Chinese and Caucasian college students, and found that socially-prescribed perfectionism appeared to be a more accurate predictor of anxiety for the Chinese group as compared to their Caucasian counterparts.
For the individualistic Caucasian Read more…
Almost one in six cases of depression among working Victorians are caused by job stress. This means more than 21,000 cases of preventable depression are caused by job stress each year, a new University of Melbourne study shows.
Stressful working conditions in this study were defined as a combination of high job demands and low control over Read more…
Buy generic cialis If walking seems too simple to be an effective fitness method, think again: taking a stroll for 30 minutes is the easiest way to lower blood pressure, according to the Department of Sport Science, Tourism and Leisure, Canterbury Christ Church University.
Exercise science researchers, Mr Andrew Scott, Dr Kate Woolf-May and Dr Ian Swaine have found that walking at a steady pace Read more…
FDA on Thursday is expected to issue an advisory that urges physicians to conduct genetic testing before prescribing GlaxoSmithKline’s antiretroviral drug abacavir to reduce allergic reactions in people taking the drug, the New York Times reports. The recommendation to conduct genetic screenings will be included in a black Read more…
GlaxoSmithKline (GSK) announced that the European Commission has issued marketing authorisation for Volibris® (ambrisentan) for the treatment of Pulmonary Arterial Hypertension (PAH) in patients classified as World Health Organisation (WHO) Functional Class II and III, to improve exercise capacity.1 Efficacy has been shown in idiopathic PAH (IPAH) and in PAH associated with connective tissue disease.1
Ambrisentan is the first Read more…
Latest News For Allergy
Keep An Eye On Allergies This Season
21 Apr 2008
Evaluating Treatment To Prevent Allergic Reactions To Food
18 Apr 2008
Alcon’s PATANASE(R) Nasal Spray Approved By FDA For Treatment Of Nasal Allergy Symptoms
17 Apr 2008
View more news…
Latest Read more…
GlaxoSmithKline (GSK) announced that the European Commission has issued marketing authorisation for Volibris® (ambrisentan) for the treatment of Pulmonary Arterial Hypertension (PAH) in patients classified as World Health Organisation (WHO) Functional Class II and III, to improve exercise capacity. [i] Efficacy has been shown in idiopathic PAH (IPAH) and in PAH associated Read more…
A new study published in the
current Journal of the American Society of Hypertension demonstrates that
the hypertension treatment olmesartan medoxomil was effective in reversing
the narrowing of the arteries that occurs in Read more…
Researchers at Boston University School of Medicine (BUSM) have, for the first time, found that angiotensin receptor blockers (ARBs) - a particular class of anti-hypertensive medicines - are associated with a striking decrease in the occurrence and progression of dementia. Buy soma pills Data from this study was presented at the 2008 International Read more…
Pfizer’s Lyrica reduced pain of fibromyalgia in patients regardless of whether they experienced symptoms of anxiety or depression at the beginning of the study, according to a pooled analysis presented today at the American Academy of Neurology annual meeting. The analysis, which looked at data pooled from previous clinical trials, also showed that Read more…
A cold slice of watermelon has long been a Fourth of July holiday staple. But according to recent studies, the juicy fruit may be better suited for Valentine’s Day.
That’s because scientists say watermelon has ingredients that deliver Viagra-like effects to the body’s blood vessels and may even increase libido.
"Buy lasix pills The more we Read more…
When it comes to allergies, both the problem and the solution are found within us. Our immune systems respond to foreign substances with an arsenal of cells. Some are programmed to "remember" invaders they’ve encountered in the past. Normally, anything previously identified as harmless is allowed to pass. Sometimes, however, the immune response goes awry, triggering an allergic reaction.
Now, researchers at NYU School of Medicine have zeroed in Read more…
A new treatment programme for cancer patients with clinical depression can significantly boost their quality of life according to new research published in the Lancet.
Cancer Research UK scientists devised the treatment programme which offers patients one-to-one sessions with Read more…
The German Institute for Quality and Efficiency in Health Care has assessed recent evidence on allergies. It found that the once controversial immune therapy against allergy symptoms can definitely help many people with allergies.
When it is green and the flowers have returned, the allergy season has hit its peak. And the number of people affected is still rising. Read more…
Men’s Health News
Plans are in the pipeline to raise awareness of health issues which affect men in particular.
The Federal Health Minister Nicola Roxon says the government has set in motion plans for the development of Australia’s first health policy for men based on a draft document Read more…
New evidence for the first time suggests that people suffering from hay fever (allergic rhinitis) will over time experience a progressive worsening of their nasal passage functioning, depending on how long they have the disorder, according to a new study published in the June 2008 edition of Otolaryngology - Head Read more…